Epstein-Barr virus type I and type II latency antigen TCD4 + epitopes that can be recognized by the majority of white populations, and applications thereof

摘要

The invention relates to immunogenic peptides from EBV type I and II latency antigens, comprising at least one T CD4+ epitope which can be recognized by the majority of individuals in the Caucasian population. The invention also relates to the diagnostic and therapeutic applications of same.